Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Comparison of Two Patient Education Methods in Women With Chronic Low Back Pain: Online Pain Education vs. AI-Driven Patient Education on Pain Beliefs, Catastrophizing, and Self-Efficacy

1. november 2026 oppdatert av: Aybike Senel, Amasya University

The goal of this study is to learn if ChatGPT-generated answers can improve pain beliefs, catastrophizing, and self-efficacy in women with chronic low back pain compared to supervised pain education. The main questions it aims to answer are: Does ChatGPT improve pain beliefs, catastrophizing, and self-efficacy in women with chronic low back pain? Is ChatGPT as effective as supervised pain education? Participants will: complete baseline questionnaires online, attend a single 30-60 minute online session (randomly assigned to either a supervised pain education presentation or asking frequently questions about low back pain to ChatGPT)

Studieoversikt

Status

Har ikke rekruttert ennå

Detaljert beskrivelse

This study aims to investigate the effects of responses provided by ChatGPT to frequently asked questions about low back pain on pain beliefs, catastrophizing, and self-efficacy in women with chronic low back pain, and to compare them with supervised patient education.

Designed as a randomized controlled trial, this research will be conducted with female participants aged 18-65 with a history of low back pain lasting longer than 3 months will be included. Eligible volunteers will be randomly allocated to either the supervised education group or the ChatGPT group. A single 30-minute session will be conducted with participants in both groups. Participants' pain beliefs will be evaluated using the Pain Beliefs Questionnaire, catastrophizing levels using the Pain Catastrophizing Scale, and self-efficacy levels using the Pain Self-Efficacy Questionnaire. Assessments will be administered twice: immediately before and immediately after the session.

Within the scope of this study, the impact of information obtained from ChatGPT-one of today's widely used and easily accessible AI chatbots-on chronic low back pain, will be revealed. Additionally, comparing these effects with those of supervised pain education may provide a significant contribution to health literacy regarding low back pain.

Studietype

Intervensjonell

Registrering (Antatt)

60

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria:

  • To be between 30 and 60 years old
  • To have pain lasting longer than 3 months
  • To have pain intensity greater than 4 out of 10
  • Ability to communicate effectively and understand the study procedures
  • Ability to conduct video calls via Microsoft Teams and complete questionnaires via Google Forms.
  • To be volunteer to participate in the study

Exclusion Criteria:

  • Having previously received pain neuroscience/education or having asked questions regarding pain to ChatGPT or any other chatbots
  • Being pregnant
  • Diagnosis of endocrinological, psychiatric, urogenital, neurological, dermatological, cardiorespiratory, or musculoskeletal diseases, and/or sleep disorders that could interfere with the study outcomes
  • Currently undergoing other treatments for low back pain (e.g., physical therapy, acupuncture).

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Patient Education Group

Responses to frequently asked questions about low back pain will be developed within the framework of Pain Neuroscience Education, based on Butler and Moseley's (2003) book "Explain Pain" and current low back pain management guidelines. The prepared responses will be compiled into a PowerPoint presentation and delivered by one of the researchers via screen sharing on Microsoft Teams. The presentation is planned to last approximately 30-60 minutes. All participants in this group will attend the presentation conducted by the same researcher. Participants will not be allowed to ask any additional questions during the session.

Aktiv komparator: ChatGPT Group

Frequently asked questions about low back pain found in the literature will be sent to participants via email. During screen sharing on Microsoft Teams, participants will be asked to submit these questions one by one to an AI chatbot and carefully read the responses. The same researcher will accompany the participants while they ask all the questions to the AI tool. This process is planned to take approximately 30-60 minutes. Participants will not be allowed to ask any additional questions during the session. However, once all evaluations are completed, a PDF version of the presentation prepared by the researchers will also be shared with participants in this group.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Pain Beliefs Questionnaire
Tidsramme: baseline

Participants' pain beliefs will be evaluated using the Pain Beliefs Questionnaire. The scale uses a 6-point Likert-type rating ranging from 0 to 5 (never, rarely, sometimes, often, almost always, and always) and consists of 12 items. Two subscale scores are obtained from the questionnaire: psychological pain belief and organic pain belief. A higher score indicates a higher pain belief related to that subscale, whereas a lower score indicates a lower pain belief. The validity and reliability study of the scale has been conducted.

baseline
Pain Catastrophizing Scale
Tidsramme: baseline

Participants' level of pain catastrophizing will be evaluated using the Pain Catastrophizing Scale (PCS). The PCS is a 13-item Likert-type self-report scale. Each item is rated on a 0-4 scale. The total score ranges from 0 to 52. It comprises three subscales: rumination, magnification, and helplessness. Higher scores indicate higher levels of catastrophizing. The validity and reliability study of the scale has been conducted.

baseline
Pain Self-Efficacy Questionnaire
Tidsramme: baseline

Participants' level of pain-related self-efficacy will be evaluated using the Pain Self-Efficacy Questionnaire (PSEQ). Based on Bandura's concept of self-efficacy, the questionnaire is a 10-item self-report tool designed to measure the degree of confidence in performing a range of activities despite pain. Among questionnaires evaluating pain self-efficacy, it is a practical tool due to its brevity, possesses well-proven validity and reliability, and measures multiple domains of self-efficacy related to social and physical functioning. Each item is rated on a 7-point Likert-type scale (0: Not at all confident, 6: Completely confident). The total score ranges from 0 to 60, with higher scores indicating greater self-efficacy for functionality despite pain. The validity and reliability study of the questionnaire has been conducted.

baseline
Pain Beliefs Questionnaire
Tidsramme: immediately after intervention

Participants' pain beliefs will be evaluated using the Pain Beliefs Questionnaire. The scale uses a 6-point Likert-type rating ranging from 0 to 5 (never, rarely, sometimes, often, almost always, and always) and consists of 12 items. Two subscale scores are obtained from the questionnaire: psychological pain belief and organic pain belief. A higher score indicates a higher pain belief related to that subscale, whereas a lower score indicates a lower pain belief. The validity and reliability study of the scale has been conducted.

immediately after intervention
Pain Catastrophizing Scale
Tidsramme: immediately after intervention

Participants' level of pain catastrophizing will be evaluated using the Pain Catastrophizing Scale (PCS). The PCS is a 13-item Likert-type self-report scale. Each item is rated on a 0-4 scale. The total score ranges from 0 to 52. It comprises three subscales: rumination, magnification, and helplessness. Higher scores indicate higher levels of catastrophizing. The validity and reliability study of the scale has been conducted.

immediately after intervention
Pain Self-Efficacy Questionnaire
Tidsramme: immediately after intervention

Participants' level of pain-related self-efficacy will be evaluated using the Pain Self-Efficacy Questionnaire (PSEQ). Based on Bandura's concept of self-efficacy, the questionnaire is a 10-item self-report tool designed to measure the degree of confidence in performing a range of activities despite pain. Among questionnaires evaluating pain self-efficacy, it is a practical tool due to its brevity, possesses well-proven validity and reliability, and measures multiple domains of self-efficacy related to social and physical functioning. Each item is rated on a 7-point Likert-type scale (0: Not at all confident, 6: Completely confident). The total score ranges from 0 to 60, with higher scores indicating greater self-efficacy for functionality despite pain. The validity and reliability study of the questionnaire has been conducted.

immediately after intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. desember 2026

Primær fullføring (Antatt)

1. januar 2028

Studiet fullført (Antatt)

1. januar 2028

Datoer for studieregistrering

Først innsendt

20. september 2026

Først innsendt som oppfylte QC-kriteriene

1. november 2026

Først lagt ut (Faktiske)

4. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

4. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

1. november 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere